The Single Large-Scale mtDNA Deletion Sydrome: Natural History Study (PS-NHS) aims to collect data on standardized clinical outcomes, store data on the Champ Foundation Registry (CFR) and make this data available to researchers, clinicians, and industry partners who are studying SLSMDS to answer questions regarding the disease, including its causes, potential treatments, and other topics. A secondary aim is to analyze the data to understand research questions relating to the natural history of SLSMDS.
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Columbia Neurological Scale
Timeframe: 2 years
PEDI-CAT assessment
Timeframe: 2 years
International Pediatric Mitochondrial Disease Scale
Timeframe: 2 years
Scale for Assessment and Rating of Ataxia
Timeframe: 2 years
Balance test
Timeframe: 2 years
Coordination test
Timeframe: 2 years
2 or 6 minute walk test
Timeframe: 2 years
Strength test
Timeframe: 2 years
Elizabeth Reynolds, PhD
Hearing testing
Timeframe: 2 years
EKG rhythm
Timeframe: 2 years
EKG PR interval
Timeframe: 2 years
EKG QRS interval
Timeframe: 2 years
Echo
Timeframe: 2 years
BNP
Timeframe: 2 years
Lipid panel
Timeframe: 2 years
Cortisol
Timeframe: 2 years
PTH
Timeframe: 2 years
Calcium
Timeframe: 2 years
Vitamin D
Timeframe: 2 years
Growth hormone
Timeframe: 2 years
IGF1
Timeframe: 2 years
TSH
Timeframe: 2 years
FT4 and T3
Timeframe: 2 years
HbA1c
Timeframe: 2 years
C-peptide
Timeframe: 2 years
Fasting Plasma Glucose (FPG)
Timeframe: 2 years
Fructosamine
Timeframe: 2 years
Amylase
Timeframe: 2 years
Comprehensive Metabolic Panel
Timeframe: 2 years
Lipase
Timeframe: 2 years
PT/PTT
Timeframe: 2 years
Stool elastase
Timeframe: 2 years
Height
Timeframe: 2 years
Weight
Timeframe: 2 years
Orbitofrontal cortex (OFC)
Timeframe: 2 years
Complete blood count with differential
Timeframe: 2 years
Ferritin
Timeframe: 2 years
Iron
Timeframe: 2 years
Reticulocytes
Timeframe: 2 years
Reticulocytes
Timeframe: 2 years
Number of transfusions
Timeframe: 2 years
Acylcarnitines (plasma)
Timeframe: 2 years
Amino acids (plasma and urine)
Timeframe: 2 years
Organic acids (urine)
Timeframe: 2 years
Lactate
Timeframe: 2 years
Glutathione
Timeframe: 2 years
GDF15
Timeframe: 2 years
Visual exam
Timeframe: 2 years
ERG/OCT
Timeframe: 2 years
Ptosis/ophthalmoplegia
Timeframe: 2 years
Cystatin C
Timeframe: 2 years
Magnesium
Timeframe: 2 years
Phosphate
Timeframe: 2 years
Urine Electrolytes
Timeframe: 2 years
Urine protein
Timeframe: 2 years
Urine amino acids
Timeframe: 2 years
Facial dysmorphology assessment
Timeframe: 2 years